[Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks]
- PMID: 17513206
[Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks]
Abstract
Objective: To investigate the relative roles of serum apolipoprotein (apo) B and low density lipoprotein (LDL)-cholesterol levels in predicting incident coronary heart disease (CHD). Whether apo B/apo A-I ratio has advantage over apo B in this prediction constitutes a secondary aim.
Methods: Prospective evaluation of 1138 men and 1210 women, aged 28-74 years participating in the TEKHARF survey 1997/98 with a mean 5.9-years' follow-up in whom serum apo B was determined. Tertiles of LDL-cholesterol were formed by cut points of 130 and 100 mg/dl, and of apo B by 120 and 95 mg/dl. Metabolic syndrome was defined by modified ATPIII criteria. Nonfatal CHD diagnosis was based on history of angina and myocardial revascularization, physical examination of the cardiovascular system and Minnesota coding of resting electrocardiograms.
Results: Apolipoprotein B showed significant correlations with a greater number of parameters than did LDL-cholesterol. Incident CHD was not significantly predicted in age-adjusted logistic regression by LDL-cholesterol but by apo B concentrations in men with a relative risk (RR) 1.005. Apolipoprotein B level >120 vs <95 mg/dl retained significance in both genders combined, even after adjustment for waist girth and log C-reactive protein. The top (>1.02) compared with the bottom bracket of apo B/A-I ratio, though not reaching significantly predictive values among women, did significantly predict in men incident CHD with a RR 1.89.
Conclusions: Apolipoprotein B, which marks small, dense LDL particles in plasma, is a better predictor of incident CHD than LDL-cholesterol among Turkish adults. While in the prediction of CHD apo B level should be preferred in women, an apo B/A-I ratio >1.02 has advantages over the latter in men. It is time to create the environment (at least in our cities) for measuring in equipped laboratories apo B, which has advantages over measurements that permit calculation of LDL-cholesterol.
Comment in
-
[Total variation of LDL-cholesterol and apolipoprotein B/ Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].Anadolu Kardiyol Derg. 2007 Sep;7(3):331-2; author reply 332. Anadolu Kardiyol Derg. 2007. PMID: 17785232 Turkish. No abstract available.
Similar articles
-
Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.Int J Obes (Lond). 2007 Jul;31(7):1119-25. doi: 10.1038/sj.ijo.0803552. Epub 2007 Feb 13. Int J Obes (Lond). 2007. PMID: 17299378
-
Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.Am J Cardiol. 2006 Apr 1;97(7):997-1001. doi: 10.1016/j.amjcard.2005.10.060. Epub 2006 Feb 13. Am J Cardiol. 2006. PMID: 16563904
-
Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.Anadolu Kardiyol Derg. 2004 Sep;4(3):236-45. Anadolu Kardiyol Derg. 2004. PMID: 15355827 Review.
-
Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.Anadolu Kardiyol Derg. 2006 Dec;6(4):314-21. Anadolu Kardiyol Derg. 2006. PMID: 17162275
-
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.J Intern Med. 2006 Mar;259(3):247-58. doi: 10.1111/j.1365-2796.2006.01616.x. J Intern Med. 2006. PMID: 16476102
Cited by
-
Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.Am J Clin Nutr. 2010 Oct;92(4):714-22. doi: 10.3945/ajcn.2009.28532. Epub 2010 Sep 8. Am J Clin Nutr. 2010. PMID: 20826623 Free PMC article. Clinical Trial.
-
Association of rs2072183 SNP and serum lipid levels in the Mulao and Han populations.Lipids Health Dis. 2012 May 30;11:61. doi: 10.1186/1476-511X-11-61. Lipids Health Dis. 2012. PMID: 22646906 Free PMC article.
-
Discordance of Low-Density Lipoprotein Cholestrol and Non-High-Density Lipoprotein Cholestrol and Coronary Artery Disease Severity.Arq Bras Cardiol. 2020 Mar;114(3):469-475. doi: 10.36660/abc.20190091. Arq Bras Cardiol. 2020. PMID: 32049158 Free PMC article. English, Portuguese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials